Table 1.
The clinicopathology features and survival time distribution of MB patients
| MB | Number of patients | Median survival times | P value |
|---|---|---|---|
| 44 cases |
(Death) |
X ± s (months) |
(<0.05) |
|
Sex |
|
|
0.346 |
| Male |
27(19) |
15 ± 5.769 |
|
| Female |
17(12) |
24 ± 11.406 |
|
|
Resection stage |
|
|
|
| Total resection |
33(17) |
35 ± 4.763 |
0.0352 |
| Partial resection |
11(9) |
20 ± 6.020 |
|
|
Therapy |
|
|
<0.0001 |
| Surgery only |
27(23) |
10 ± 0.975 |
|
| Surgery + Radiotherapy |
17(3) |
53 ± 10.29 |
|
|
Ki67 |
|
|
0.051 |
| 0,1+, 2+ |
21(8) |
51 ± 10.29 |
|
| 3+ |
13(8) |
20 ± 5.503 |
|
|
EGFR (IHC) (34 cases) |
|
|
0.0001 |
| 0,1+, 2+ |
20(5) |
53 ± 20.82 |
|
| 3+ |
14(11) |
11 ± 3.338 |
|
|
EGFR (FISH) (34 cases) |
|
|
0.002 |
| Negative |
15(5) |
53 ± 19.96 |
|
| Positive | 19(11) | 20 ± 7.028 |